Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Haoyuan Chemexpress Co's Days Inventory or its related term are showing as below:
SHSE:688131'
s Days Inventory Range Over the Past 10 Years
Min: 226.05 Med: 308.03 Max: 364.04
Current: 320.21
During the past 13 years, Shanghai Haoyuan Chemexpress Co's highest Days Inventory was 364.04. The lowest was 226.05. And the median was 308.03.
SHSE:688131's Days Inventory is ranked worse than 86.32% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs SHSE:688131: 320.21
Inventory Turnover measures how fast the company turns over its inventory within a year.
Shanghai Haoyuan Chemexpress Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.24.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Shanghai Haoyuan Chemexpress Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.00.
Shanghai Haoyuan Chemexpress Co (SHSE:688131) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Shanghai Haoyuan Chemexpress Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Shanghai Haoyuan Chemexpress Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Shanghai Haoyuan Chemexpress Co Days Inventory Related Terms
Shanghai Haoyuan Chemexpress Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haoyuan Chemexpress Co Days Inventory Chart
SHSE:688131 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haoyuan Chemexpress Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a Days Inventory of 384.26 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. This is 25% above median its historical median of 308.03. Over the past decade, Shanghai Haoyuan Chemexpress Co's Days Inventory has ranged from 226.05 to 364.04. According to the industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #795 out of 921 companies in the Drug Manufacturers industry, placing it in the top 86.3%.
Is Shanghai Haoyuan Chemexpress Co's Days Inventory too high?
Shanghai Haoyuan Chemexpress Co's current Days Inventory of 384.26 is 25% above median its 10-year median of 308.03. Over the past 10 years, this metric has ranged from a low of 226.05 to a high of 364.04. The Drug Manufacturers industry median Days Inventory is 164.48. Shanghai Haoyuan Chemexpress Co's value of 384.26 is 133.6% above this industry median. Based on the distribution chart, Shanghai Haoyuan Chemexpress Co ranks #795 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #795 out of 921 companies for Days Inventory. This places Shanghai Haoyuan Chemexpress Co in the lower half of its industry. The industry median Days Inventory is 164.48. Shanghai Haoyuan Chemexpress Co's value of 384.26 is 133.6% above this benchmark. Historically, Shanghai Haoyuan Chemexpress Co's own Days Inventory has ranged from 226.05 to 364.04 over the past decade. While the company's 10-year median is 308.03 vs. the industry median of 164.48, Shanghai Haoyuan Chemexpress Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Haoyuan Chemexpress Co's current Days Inventory of 384.26 is 133.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Haoyuan Chemexpress Co's current Days Inventory is 384.26, which is 25% above median its own 10-year median of 308.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Fairly Valued. The stock's GF Value™ is ¥65.96, compared to a current price of ¥68.15 — trading 3.3% above its estimated fair value. The current Days Inventory is 384.26, which is 25% above median its 10-year median of 308.03 and 133.6% above the Drug Manufacturers industry median of 164.48. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current Days Inventory is 384.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued.
The current stock price of ¥68.15 is trading 3.3% above its estimated GF Value™ of ¥65.96.
GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Fairly Valued.
Key valuation signals for SHSE:688131:
Days Inventory: 384.26 (25% above median its 10-year median of 308.03)
GF Value™: ¥65.96 vs. price of ¥68.15 (3.3% above fair value)
Industry Position: 133.6% above the Drug Manufacturers median (#795 of 921)
No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Haoyuan Chemexpress Co Business Description
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
93GF Score
Get the complete analysis for SHSE:688131
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688131 has been successfully added to your 
